Marc Foretz

26.4k total citations · 10 hit papers
187 papers, 20.1k citations indexed

About

Marc Foretz is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Marc Foretz has authored 187 papers receiving a total of 20.1k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Molecular Biology, 95 papers in Surgery and 51 papers in Physiology. Recurrent topics in Marc Foretz's work include Metabolism, Diabetes, and Cancer (129 papers), Pancreatic function and diabetes (91 papers) and Adipose Tissue and Metabolism (34 papers). Marc Foretz is often cited by papers focused on Metabolism, Diabetes, and Cancer (129 papers), Pancreatic function and diabetes (91 papers) and Adipose Tissue and Metabolism (34 papers). Marc Foretz collaborates with scholars based in France, United States and United Kingdom. Marc Foretz's co-authors include Benoı̂t Viollet, Bruno Guigas, Fabrizio Andréelli, Jocelyne Leclerc, Pascal Ferré, Fabienne Foufelle, Luc Bertrand, C Guichard, Kei Sakamoto and Michaël Pollak and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Marc Foretz

182 papers receiving 19.9k citations

Hit Papers

Cellular and molecular mechanisms of metformin: ... 1999 2026 2008 2017 2011 2014 2010 2013 1999 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cellular and molecular mechanisms of metformin: an overview
    2011 1.4k citations Benoı̂t Viollet, Bruno Guigas et al. profile →
  2. Metformin: From Mechanisms of Action to Therapies
    2014 1.1k citations Marc Foretz, Bruno Guigas et al. profile →
  3. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
    2010 962 citations Marc Foretz, Benoı̂t Viollet et al. profile →
  4. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
    2013 662 citations Marc Foretz, Benoı̂t Viollet et al. profile →
  5. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes
    1999 611 citations Marc Foretz, Pascal Ferré et al. profile →
  6. AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol
    2009 542 citations Sung-Jun Park, Hyeog Kang et al. Diabetes profile →
  7. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status
    2016 519 citations Benoı̂t Viollet, Marc Foretz et al. profile →
  8. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
    2019 453 citations Marc Foretz, Bruno Guigas et al. profile →
  9. Metformin: update on mechanisms of action and repurposing potential
    2023 360 citations Marc Foretz, Bruno Guigas et al. profile →
  10. AMPK in skeletal muscle function and metabolism
    2017 352 citations Rasmus Kjøbsted, Marc Foretz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Foretz France 70 13.0k 5.9k 5.2k 3.7k 3.6k 187 20.1k
Simon A. Hawley United Kingdom 47 16.1k 1.2× 6.9k 1.2× 4.1k 0.8× 2.8k 0.8× 3.2k 0.9× 59 20.9k
Kazuyuki Tobe Japan 70 9.9k 0.8× 3.4k 0.6× 4.8k 0.9× 3.3k 0.9× 3.7k 1.0× 307 18.5k
Gregory R. Steinberg Canada 78 12.3k 0.9× 4.7k 0.8× 8.8k 1.7× 3.3k 0.9× 6.2k 1.7× 246 23.5k
David E. Moller United States 72 17.1k 1.3× 5.3k 0.9× 6.9k 1.3× 5.8k 1.6× 4.5k 1.3× 169 26.2k
Fabienne Foufelle France 63 10.8k 0.8× 5.7k 1.0× 6.5k 1.2× 3.5k 0.9× 6.7k 1.9× 135 20.9k
Nada A. Abumrad United States 75 9.5k 0.7× 3.2k 0.5× 5.4k 1.0× 2.4k 0.7× 3.1k 0.9× 179 18.4k
Yasuo Terauchi Japan 60 7.8k 0.6× 4.4k 0.7× 3.9k 0.7× 5.4k 1.5× 4.3k 1.2× 377 17.3k
Nicolas Musi United States 56 8.7k 0.7× 3.6k 0.6× 5.1k 1.0× 4.0k 1.1× 3.3k 0.9× 150 15.6k
Kohjiro Ueki Japan 73 10.0k 0.8× 3.9k 0.7× 6.8k 1.3× 4.8k 1.3× 7.2k 2.0× 240 22.6k
Shun Ishibashi Japan 67 6.6k 0.5× 6.4k 1.1× 3.0k 0.6× 4.1k 1.1× 3.2k 0.9× 360 17.2k

Countries citing papers authored by Marc Foretz

Since Specialization
Citations

This map shows the geographic impact of Marc Foretz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Foretz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Foretz more than expected).

Fields of papers citing papers by Marc Foretz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Foretz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Foretz. The network helps show where Marc Foretz may publish in the future.

Co-authorship network of co-authors of Marc Foretz

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Foretz. A scholar is included among the top collaborators of Marc Foretz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Foretz. Marc Foretz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tokavanich, Nicha, Christian Castro, Yuki Arai, et al.. (2025). Control of alveolar bone development, homeostasis, and socket healing by salt-inducible kinases. Journal of Bone and Mineral Research. 40(5). 656–670.
2.
O’Dwyer, Conor, et al.. (2024). Myeloid AMPK signaling restricts fibrosis but is not required for metformin improvements during CDAHFD-induced NASH in mice. Journal of Lipid Research. 65(6). 100564–100564. 3 indexed citations
3.
Hughey, Curtis C., Deanna P. Bracy, E. Patrick Donahue, et al.. (2023). Exercise training adaptations in liver glycogen and glycerolipids require hepatic AMP-activated protein kinase in mice. American Journal of Physiology-Endocrinology and Metabolism. 326(1). E14–E28. 5 indexed citations
4.
Hayes, Emily, et al.. (2023). Salt-inducible kinases regulate androgen synthesis in theca cells by enhancing CREB signaling. Molecular and Cellular Endocrinology. 577. 112030–112030. 3 indexed citations
5.
Lindahl, Maria, Andreas M. Fritzen, Björn Morén, et al.. (2023). Salt‐inducible kinases are required for glucose uptake and insulin signaling in human adipocytes. Obesity. 31(10). 2515–2529. 4 indexed citations
6.
Pescador, Nuria, Vera Francisco, Patricia Vázquez, et al.. (2021). Metformin reduces macrophage HIF1α-dependent proinflammatory signaling to restore brown adipocyte function in vitro. Redox Biology. 48. 102171–102171. 33 indexed citations
7.
Wein, Marc N., Marc Foretz, David E. Fisher, Ramnik J. Xavier, & Henry M. Kronenberg. (2018). Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential. Trends in Endocrinology and Metabolism. 29(10). 723–735. 95 indexed citations
8.
Marion, Allison, et al.. (2018). AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development. EBioMedicine. 28. 194–209. 157 indexed citations
9.
Kjøbsted, Rasmus, Jesper B. Birk, Marc Foretz, et al.. (2016). Enhanced Muscle Insulin Sensitivity After Contraction/Exercise Is Mediated by AMPK. Diabetes. 66(3). 598–612. 132 indexed citations
10.
Vauthier, Virginie, Patty Chen, Chamsy Sarkis, et al.. (2016). Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling. Molecular Metabolism. 6(1). 159–172. 11 indexed citations
11.
Mahmoud, Amira D., Utibe‐Abasi S. Udoh, Maurits A. Jansen, et al.. (2015). AMP-activated Protein Kinase Deficiency Blocks the Hypoxic Ventilatory Response and Thus Precipitates Hypoventilation and Apnea. American Journal of Respiratory and Critical Care Medicine. 193(9). 1032–1043. 36 indexed citations
12.
Sun, Gao, Gabriela da Silva Xavier, Tracy Gorman, et al.. (2015). LKB1 and AMPKα1 are required in pancreatic alpha cells for the normal regulation of glucagon secretion and responses to hypoglycemia. Molecular Metabolism. 4(4). 277–286. 22 indexed citations
13.
Foretz, Marc, et al.. (2015). AMPK couples oxygen to energy supply at the whole-body level by delivering increased drive to breathe during hypoxia and thus protects against apnoea. Proceedings of The Physiological Society. 2 indexed citations
14.
Hasenour, Clinton M., Curtis C. Hughey, Freyja D. James, et al.. (2014). 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo. Journal of Biological Chemistry. 289(9). 5950–5959. 57 indexed citations
15.
García, Marcos Ríos, Marc Foretz, Benoı̂t Viollet, et al.. (2013). AMPK Activation by Oncogenesis Is Required to Maintain Cancer Cell Proliferation in Astrocytic Tumors. Cancer Research. 73(8). 2628–2638. 104 indexed citations
16.
Rolf, Julia, Marouan Zarrouk, David K. Finlay, et al.. (2013). AMPKα1: A glucose sensor that controls CD8 T‐cell memory. European Journal of Immunology. 43(4). 889–896. 191 indexed citations
17.
Schuhmacher, Swenja, Marc Foretz, Maike Knorr, et al.. (2010). Abstract 13469: Alpha1-AMPK Deletion Enhances Endothelial Dysfunction and Vascular Oxidative Stress During Chronic Angiotensin II Treatment by Upregulation of Nox2. Circulation. 122. 1 indexed citations
18.
Park, Sung-Jun, Hyeog Kang, Shutong Yang, et al.. (2009). AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol. Diabetes. 59(3). 554–563. 542 indexed citations breakdown →
19.
Foretz, Marc, Bruno Guigas, & Benoı̂t Viollet. (2006). Du cancer au traitement du diabète : le suppresseur de tumeur LKB1 comme nouvelle cible pharmacologique. médecine/sciences. 22(4). 348–350. 2 indexed citations
20.
Woods, Angela, Dalila Azzout‐Marniche, Marc Foretz, et al.. (2000). Characterization of the Role of AMP-Activated Protein Kinase in the Regulation of Glucose-Activated Gene Expression Using Constitutively Active and Dominant Negative Forms of the Kinase. Molecular and Cellular Biology. 20(18). 6704–6711. 351 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon A. Hawley Breakdown of academic impact, for papers by Kazuyuki Tobe Breakdown of academic impact, for papers by Gregory R. Steinberg Breakdown of academic impact, for papers by David E. Moller Breakdown of academic impact, for papers by Fabienne Foufelle Breakdown of academic impact, for papers by Nada A. Abumrad Breakdown of academic impact, for papers by Yasuo Terauchi Breakdown of academic impact, for papers by Nicolas Musi Breakdown of academic impact, for papers by Kohjiro Ueki Breakdown of academic impact, for papers by Shun Ishibashi
Rankless by CCL
2026